SCHEMBL19920010

SCHEMBL19920010

O=CCc1cccc(Cn2cccn2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.60
▸ TSHR P16473 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ GLS O94925 3/20 0.49
▸ PRKACA P17612 1/20 0.48
▸ PRKACG P22612 1/20 0.48
▸ PRKACB P22694 1/20 0.48
▸ HDAC1 Q13547 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.46
▸ MAPT P10636 3/20 0.45
▸ GAA P10253 2/20 0.45
▸ ALOX15 P16050 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ CA12 O43570 1/20 0.44
▸ CA1 P00915 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ CA9 Q16790 1/20 0.44
▸ GRK6 P43250 1/20 0.43
▸ USP2 O75604 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7488613 0.88 HTT (0.49) HTTTSHRKMT2AMEN1GLS
SCHEMBL14256403 0.88 HTT (0.68) HTTTSHRKMT2AMEN1GLS
SCHEMBL2640844 0.83 HTT (0.56) HTTTSHRKMT2AMEN1GLS
SCHEMBL895371 0.83 HTT (0.58) HTTTSHRKMT2AMEN1GLS
SCHEMBL13933220 0.81 HTT (0.60) HTTTSHRKMT2AMEN1GLS
SCHEMBL14987117 0.80 HTT (0.63) HTTTSHRKMT2AMEN1GLS
SCHEMBL110733 0.80 HTT (0.59) HTTTSHRKMT2AMEN1GLS
SCHEMBL29809114 0.80 HTT (0.59) HTTTSHRKMT2AMEN1GLS
SCHEMBL14987118 0.80 HTT (0.59) HTTTSHRKMT2AMEN1GLS
SCHEMBL10244204 0.79 HTT (0.57) HTTTSHRKMT2AMEN1GLS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3277276-B1 METHODS OF ADMINISTERING GLUTAMINASE INHIBITORS CALITHERA BIOSCIENCES INC (US) 2020-11-04 — — EP disclosed
EP-2782570-B1 HETEROCYCLIC INHIBITORS OF GLUTAMINASE CALITHERA BIOSCIENCES INC (US) 2019-09-18 — — EP disclosed
WO-2018039442-A1 TREATMENT OF CANCER WITH INHIBITORS OF GLUTAMINASE CALITHERA BIOSCIENCES, INC. (US) 2018-03-01 — — WO disclosed
Send feedback